GILEAD SCIENCES INC Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for August 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2016 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 3,225 | 0 | 109,743 | 113 K to 109.7 K (-2.85 %) |
| Aug 26 2016 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 2,800 | 0 | 2,316,849 | 2.3 M to 2.3 M (-0.12 %) |
| Aug 25 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Sell | S | 81.97 | 3,500 | 286,899 | 0 | 3.5 K to 0 (-100.00 %) |
| Aug 25 2016 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
| Aug 23 2016 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 0.00 | 1,339 | 0 | 1,339 | |
| Aug 23 2016 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 81.00 | 5,611 | 454,491 | 5,611 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 183 | 4,558 | 26,043 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,817 | 73,698 | 4,803 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.81 | 2,000 | 159,620 | 62,305 | 64.3 K to 62.3 K (-3.11 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 183 | 4,558 | 64,305 | 64.1 K to 64.3 K (+0.29 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,817 | 73,698 | 64,122 | 62.3 K to 64.1 K (+2.92 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 79.47 | 1,317 | 104,662 | 62,305 | 63.6 K to 62.3 K (-2.07 %) |
| Aug 02 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 63,622 | 61.1 K to 63.6 K (+4.09 %) |